Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Nichi-Iko
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
NI-071
(infliximab biosimilar) / Sanofi, Nichi-Iko, Aprogen, Elea Labs
Nepexto
(etanercept biosimilar) / Biocon, Lupin, YL Biologics, Nichi-Iko, Viatris
